NYSE · ITGR
Healthcare · Medical - Devices
$126.05
Up+$0.15 (+0.12%)
Updated Sep 11, 2026, 4:39 PM
SID Score
6.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
ITGR closed at $126.05 after 20 trading sessions, up 0.79% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $126.00 | $126.13 | $125.87 | $126.05 | 554.46K |
| Sep 9, 2026 | $126.31 | $126.44 | $125.86 | $125.86 | 1.13M |
| Sep 8, 2026 | $126.30 | $126.45 | $126.20 | $126.20 | 561.46K |
| Sep 4, 2026 | $125.84 | $126.795 | $125.84 | $126.50 | 1.61M |
| Sep 3, 2026 | $125.39 | $125.60 | $125.37 | $125.50 | 653.52K |
| Sep 2, 2026 | $125.41 | $125.45 | $125.27 | $125.31 | 642.07K |
| Sep 1, 2026 | $125.31 | $125.50 | $125.30 | $125.39 | 1.17M |
| Aug 31, 2026 | $125.30 | $125.40 | $125.25 | $125.25 | 674.68K |
| Aug 28, 2026 | $125.45 | $125.45 | $125.23 | $125.33 | 569.65K |
| Aug 27, 2026 | $125.32 | $125.46 | $125.29 | $125.30 | 461.01K |
| Aug 26, 2026 | $125.35 | $125.49 | $125.12 | $125.19 | 456.64K |
| Aug 25, 2026 | $125.15 | $125.49 | $125.15 | $125.39 | 681.85K |
| Aug 24, 2026 | $125.35 | $125.35 | $124.84 | $125.07 | 754.4K |
| Aug 21, 2026 | $125.40 | $125.44 | $125.15 | $125.20 | 929.53K |
| Aug 20, 2026 | $125.30 | $125.47 | $125.18 | $125.21 | 964.1K |
| Aug 19, 2026 | $125.29 | $125.39 | $125.05 | $125.30 | 657.96K |
| Aug 18, 2026 | $125.20 | $125.29 | $125.04 | $125.09 | 761.33K |
| Aug 17, 2026 | $125.23 | $125.33 | $125.08 | $125.08 | 429.99K |
| Aug 14, 2026 | $125.15 | $125.44 | $125.14 | $125.26 | 368.66K |
| Aug 13, 2026 | $125.40 | $125.44 | $124.995 | $125.06 | 1.26M |
The latest Smart Investors Daily articles mentioning ITGR.
ITGR research
Company profile and research snapshot.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 14, 2026 | Benchmark | Hold | — |
| Aug 4, 2026 | Wells Fargo | Equal-Weight | — |
| Aug 4, 2026 | Freedom Capital Markets | Hold | — |
| Aug 4, 2026 | Truist Securities | Hold | — |
| Aug 4, 2026 | Oppenheimer | Perform | — |
No generated briefing is available yet.
Benzinga · Aug 3, 2026
Under the terms of the agreement, Integer stockholders will receive $127 per share, representing a premium of approximately 51.8% to Integer’s closing share price on April 29, 2026, the date prior to the Company’s
Benzinga · Jul 31, 2026
https://www.wsj.com/business/deals/kkr-near-deal-to-buy-integer-holdings-485461fa
Benzinga · Jul 31, 2026
https://www.wsj.com/business/deals/kkr-near-deal-to-buy-integer-holdings-485461fa
Fintel · Jul 23, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ITGR.
